Cargando…

The Prognostic Value of Pre-treatment Hemoglobin (Hb) in Patients With Advanced or Metastatic Gastric Cancer Treated With Immunotherapy

BACKGROUND: Biomarkers such as prevailing PD-L1 expression and TMB have been proposed as a way of predicting the outcome of immunotherapy in patients with advanced gastric cancer (AGC) and metastatic gastric cancer (MGC). Our study aims to investigate whether there is a link between pretreatment hem...

Descripción completa

Detalles Bibliográficos
Autores principales: Gou, Miaomiao, Zhang, Yong, Liu, Tiee, Qu, Tongtong, Si, Haiyan, Wang, Zhikuan, Yan, Huan, Qian, Niansong, Dai, Guanghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239234/
https://www.ncbi.nlm.nih.gov/pubmed/34211839
http://dx.doi.org/10.3389/fonc.2021.655716

Ejemplares similares